+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Berbamine (CAS 478-61-5) Global Market Research Report 2024 - Product Thumbnail Image

Berbamine (CAS 478-61-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Budralazine (CAS 36798-79-5) Global Market Research Report 2024 - Product Thumbnail Image

Budralazine (CAS 36798-79-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bucladesine (CAS 362-74-3) Global Market Research Report 2024 - Product Thumbnail Image

Bucladesine (CAS 362-74-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Acipimox (CAS 51037-30-0) Global Market Research Report 2024 - Product Thumbnail Image

Acipimox (CAS 51037-30-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
From
From
From
Europe Peripheral Vascular Interventions - Pipeline Insight, 2024 - Product Thumbnail Image

Europe Peripheral Vascular Interventions - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Europe
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more